<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="488">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>30/09/2005</approvaldate>
  <actrnumber>ACTRN12605000570684</actrnumber>
  <trial_identification>
    <studytitle>A randomised study to assess the efficacy of nasojejeunal verses nasogastric enteral feeding in critically ill patients during ICU stay.</studytitle>
    <scientifictitle>Efficacy of nasojejeunal enteral feeding in critically ill patients.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Critically ill patients requiring enteral feeding</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a naso-gastric tube with the addition of prokinetic agents for patients who fail to absorb their enteral nutrition.  This study compares the efficacy of nasojejunal enteral feeding with naso-gastric enteral feeding with the addition of prokinetic agents. The duration of enteral feeding will be determined by the patient's nutritional requirements and their general condition. However, data will be collected for duration of enteral feeding, 28 days or ICU discharge, whichever occurs first.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary outcome of the study is to determine if nasojejunal feeding improves efficacy of enteral feeding in critically ill patients during ICU stay.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To determine the incidence of complications with enteral feeding via nasogastric and nasojejunal routes.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To assess the efficacy of current strategies for optimising enteral feeding efficacy.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Adult patients admitted to the ICU with an expected stay of more than 48h. 2. Patients commenced on enteral feeding via nasogastric route who fail to tolerate gastric feeding due to excessive gastric aspirate volumes. 3. Patients who consent or if the patient is incompetent, the next-of-kin who consent, to inclusion in the study.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patients aged less than 18 years.2. Patients with a known allergy to promotility agents, metoclopramide or erythromycin.3. Patients with a contra-indication to nasojejunal feeding.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sequentially numbered opaque envelopes</concealment>
    <sequence>Randomisation sequence was achieved through an computer generated matrix</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>5/09/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Intensive Care Unit, RMH</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Melbourne Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Royal Melbourne Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Belinda Howe</name>
      <address>Intensive Care
Royal Melbourne Hospital
Grattan Street
Parkville VIC 3050</address>
      <phone>+61 3 93427710</phone>
      <fax>+61 3 93428812</fax>
      <email>belinda.howe@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr M Robertson</name>
      <address>Intensive Care
Royal Melbourne Hospital
Grattan Street
Parkville VIC 3050</address>
      <phone>+61 3 93427441</phone>
      <fax>+61 3 93428812</fax>
      <email>belinda.howe@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>